PART 11. CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS
CHAPTER 703. GRANTS FOR CANCER PREVENTION AND RESEARCH
The Cancer Prevention and Research Institute of Texas ("CPRIT" or "the Institute") adopts the amendments to 25 Texas Administrative Code §703.26 without changes to the proposed amendments as published in the December 3, 2021, issue of the Texas Register (46 TexReg 8173); therefore, the rule will not be republished. The amendments relate to reimbursement of clinical trial participation costs to grantees, a statutory reference to the Cancer Clinical Trial Participation Program, and non-substantive edits.
Reasoned Justification
The amendments to §703.26(f) add parking as a reimbursable clinical trial participation cost, correct the statutory reference of the Cancer Clinical Trial Participation Program to Texas Health and Safety Code Chapter 51, and correct a grammatical error. The amendment to §703.26(e) restructures the subsection without changing the substantive requirements.
Summary of Public Comments and Staff Recommendation
CPRIT received no public comments regarding the proposed amendments to §703.26; CPRIT staff recommends moving forward with adoption of the amendments.
CPRIT's Oversight Committee adopted the rule changes under the authority of the Texas Health and Safety Code Annotated § 102.108, which provides the Institute with broad rule-making authority to administer the chapter, including rules for awarding grants.
The agency certifies that legal counsel has reviewed the adoption and found it to be a valid exercise of the agency's legal authority.
Filed with the Office of the Secretary of State on February 18, 2022.
TRD-202200602
Heidi McConnell
Chief Operating Officer
Cancer Prevention and Research Institute of Texas
Effective date: March 10, 2022
Proposal publication date: December 3, 2021
For further information, please call: (512) 305-8487